Aquestive Therapeutics price target raised to $12 at Citizens on Anaphylm patents
Tweet Send to a Friend
Citizens analyst Jason Butler raised the price target on Aquestive Therapeutics (NASDAQ: AQST) to $12.00 (from $9.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
